May & Baker Nigeria plc Stock price

Equities

MAYBAKER

NGMAYBAKER01

Pharmaceuticals

End-of-day quote Nigerian Stock Exchange 06:00:00 2023-11-30 pm EST Intraday chart for May & Baker Nigeria plc 5-day change 1st Jan Change
5.000 NGN -5.66% -0.99% +16.28%
Sales 2022 14.33 B 18.18 M Sales 2023 * - Capitalization 7,419 M 9.41 M
Net income 2022 1,491 M 1.89 M Net income 2023 * - EV / Sales 2022
0,70x
Net Debt 2022 2,652 M 3.36 M Net cash position 2023 * - 0 EV / Sales 2023 * -
P/E ratio 2022
4,98x
P/E ratio 2023 *
Employees 350
Yield 2022
6,98%
Yield 2023 *
-
Free-Float 41.17%
More Fundamentals * Assessed data
Dynamic Chart
May & Baker Nigeria plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
Nigeria is working on COVID-19 vaccine, president says RE
May & Baker Nigeria plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
May & Baker Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
May & Baker Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
May & Baker Nigeria plc Reports Earnings Results for the Full Year Ended December 31, 2020 CI
May & Baker Nigeria plc Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
More news
1 day-5.66%
1 week-0.99%
Current month-5.66%
3 months+3.09%
6 months+19.05%
Current year+16.28%
More quotes
1 week
4.85
Extreme 4.85
5.30
1 month
4.50
Extreme 4.5
5.30
Current year
3.90
Extreme 3.9
6.03
1 year
3.76
Extreme 3.76
6.03
3 years
3.21
Extreme 3.21
6.03
5 years
1.79
Extreme 1.79
6.03
10 years
0.80
Extreme 0.8
6.03
More quotes
Managers TitleAgeSince
Chief Executive Officer - 2020
Director of Finance/CFO - 2013
Director/Board Member - 1995
Members of the board TitleAgeSince
Director/Board Member - 1995
Director/Board Member - 2011
Director/Board Member - 2013
More insiders
Date Price Change Volume
23-12-01 5.000 -5.66% 1,385,419
23-11-30 5.300 0.00% 163,585
23-11-29 5.300 0.00% 165,989
23-11-28 5.300 0.00% 407,385
23-11-27 5.300 +4.95% 1,472,618

End-of-day quote Nigerian Stock Exchange, December 30, 2023

More quotes
May and Baker Nigeria Plc is a diversified group organized around 2 areas of activity: - manufacturing of pharmaceutical products and vaccines (99.7% of net sales); - manufacturing and distribution of mineral water (0.3%): Lily brand. All net sales are earned in Nigeria.
More about the company

Annual profits - Rate of surprise

1st Jan change Capi.
+16.28% 11 M $
+59.64% 525 B $
+48.98% 454 B $
-10.34% 381 B $
-6.75% 262 B $
-11.26% 253 B $
-17.52% 221 B $
+2.14% 202 B $
-9.09% 200 B $
-43.58% 163 B $
Other Pharmaceuticals
  1. Stock
  2. Equities
  3. Stock May & Baker Nigeria plc - Nigerian Stock Exchange
As early as today, start finding the best investment opportunities!
Optimize my profits
fermer